Navigation Links
Scientists to employ Arctic ice and polar bears to protect diversity of world's crops

Scientists at St. Jude Children's Research Hospital have announced that a vaccine they developed a few years ago against one antigenic variant of the avian influenza virus H5N1 may protect humans against future variants of the virus. Vaccines based on this model might therefore be suitable for stockpiling for use during a pandemic (worldwide epidemic) until a new vaccine could be developed specifically against the variant causing the outbreak, the researchers said. An antigen is a molecule that stimulates production of antibodies by the immune system.

A prepublication report on the study appears in the online issue of Journal of Infectious Diseases (JID).

The researchers showed that the vaccine completely protected ferrets from a lethal nasal infection against not only the original virus the vaccine was made to thwart, but also against a newer variant that has already proved fatal to humans. The ferrets experienced a more significant reduction of virus multiplication than otherwise would have occurred, the researchers reported. Moreover, the infections failed to spread out of the upper respiratory tract to the lungs or brain.

"These findings are especially significant because ferrets are known to be an excellent and accurate model of influenza infection and immune response in humans," said Elena Govorkova, Ph.D., a staff scientist in the Department of Infectious Diseases at St. Jude. "Restricting the infection to the upper respiratory tract is important since in humans the virus has been isolated from specimens taken from the cerebrospinal fluid, feces, throat and blood serum. Therefore, limiting the spread of virus in an infected human is crucial to saving that person's life." Govorkova is the lead author of the JID paper and led the research team conducting the study.

The team also showed that the optimal strategy for vaccination of immunologically naïve individuals will be the use of two doses, which in the ferrets triggered mo
'"/>

Source:Global Crop Diversity Trust


Page: 1 2

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists decipher genome of fungus that can cause life-threatening infections
9. Scientists discover the cellular roots of graying hair
10. Scientists rid stem cell culture of key animal cells
11. Scientists develop new color-coded test for protein folding

Post Your Comments:
(Date:11/4/2009).... 21 What,s the cost of saving a t...l death resulting from prescription medication abu...ions, however, may be unaware that the lock-boxes ...rom the ticking timebomb of prescription drugs. Th...quality medical supplies, has formed an exclusive ...
(Date:11/4/2009)...7 Global Rainmakers, Inc., an inte...mp;D laboratory, today announced that the company ...ctively commercialize its suite of technologies de... offerings. ,, During the past four years, the ...evelop and deploy a series of core--but expandable...
(Date:11/4/2009)... Glencoe Software, Inc., the commer...Consortium ( http://openmicroscopy.org ), is pro... Society of Cell Biology,s exciting new project ti...en awarded a $2.5M stimulus grant through the Nati...ies program, as part of the American Reinvestment ...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Cequent to Provide Details at BIOCOM About Planned Launch of its Clinical Program 3 p m Tuesday October 27 14442 1Cequent to Provide Details at BIOCOM About Planned Launch of its Clinical Program 3 p m Tuesday October 27 14442 2The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 1The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 2The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 3ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10 S Probe 5414 1ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10 S Probe 5414 2ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10 S Probe 5414 3ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10 S Probe 5414 4
...erica,s war on terror includes fighting the dark s...rsity chemist Dr. Frank Raushel is helping with th...ize one such chemical agent, the organophosphates....y as insecticides in the 1930s but soon made their... during World War II. Raushel, who has been workin...
...restriction, a diet that is low in calories and hi...ing life in people as it is in rodents, according ...edicine in St. Louis. , Previous research had sh... percent less food can live up to 50 percent longe...pted calorie restriction in the hope that they can...
...f Colorado at Boulder reveals that air quality reg... of fine, organic particle pollutants that contrib...s Angeles region. , According to the study, a muc...iously thought is directly emitted by vehicles and..., organic particle pollutants form when reactive g...
Other Biology News:Researcher working on destruction of chemical weapons 2Researchers note differences between people and animals on calorie restriction 2Researchers note differences between people and animals on calorie restriction 3CU-Boulder study suggests air quality regulations miss key pollutants 2
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
(Date:11/5/2009)...RNewswire/ -- DSM Pharmaceutical Products today an...with Galenix, Saint Jean D,Illac, France, where DS...ring partner for Galenix commercial products on a ...te on business development opportunities co-market...he strength of Galenix in drug product development...
(Date:11/5/2009).... 5 ThermoGenesis Corp. ... products for processing and storing adult stem ce...of fiscal 2010. ,, For the quarter ended Septem...2 million, a 15 percent increase over revenues of ...Company said the key contributors to the growth in...
(Date:11/5/2009)...wire-FirstCall/ -- Transgenomic, Inc. (OTC Bulleti...or the quarter ended September 30, 2009. The Compa... that follow. ,, Third Quarter 2009 ,, The...per share for the third quarter of 2009 as compare... the third quarter of 2008. ,, Net sales were ...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...e Scientific,Inc. (OTC Bulletin Board: MLSS), the ...es, today announced that it will host its 2008 Ann...008 beginning at 10:00 AM,Eastern Time at the law ...ated at 7 Times Square in New York City., Shareho...il 25, 2008,will vote on the election of directors...
...enetics,Corporation (CellCyte) (OTC Bulletin Board... shareholders, potential investors and journalists...hing a comprehensive,Investor Room powered Web sit...tors,and journalists seeking background informatio...the information easily in the new Web site, which ...
...Medical,Innovations, Inc. (Amex: IMA ), a leading...ducts for the consumer and professional markets, a...R Capital Markets 12th Annual,Spring Investor Conf...in,New York. Ron Geraty, President, Health Managem...l attend. Their presentation is scheduled for,Wedn...
Other Biology Technology:Milestone Scientific to Host 2008 Annual Meeting of Stockholders on Thursday, June 5, 2008 in New York City 2Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008 2
Molecular Virology from Promega
...95) • This book is unique in that it brings t...ly used in the diagnosis of virus infections and a...virus isolates. Detailed protocols are presented c...rocedures, PCR for viral protocols, molecular epid...
GIBCO Graces Insect Cell Culture Medium; powder from Invitrogen
...cation Kits provide rapid and efficient removal of...roducts, and salts from PCR products (Figure 1). T...ovides two Binding Buffer options for fragments >1...gle column or 96-well plate format , takes ,Two ...
Biology Products: